JPMorgan lowered the firm’s price target on Afya (AFYA) to $21.50 from $22 and keeps a Neutral rating on the shares. The firm updated the company’s estimates as part of a Q1 preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFYA:
- Afya Limited Signals Strong 2025, Invests for 2026
- Options Volatility and Implied Earnings Moves Today, March 13, 2026
- Afya Posts Higher 2025 Revenue and Profit in Unaudited SEC Filing
- Afya Approves R$307.4 Million Dividend Payout from 2025 Earnings
- Afya Posts Strong 2025 Results, Boosts Shareholder Payouts and Raises Capital for Next Growth Cycle